Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

ProQR Therapeutics (PRQR) Return on Equity (2018 - 2023)

ProQR Therapeutics' Return on Equity history spans 3 years, with the latest figure at 0.01% for Q4 2023.

  • On a quarterly basis, Return on Equity changed 0.0% to 0.01% in Q4 2023 year-over-year; TTM through Dec 2023 was 0.01%, a 0.0% change, with the full-year FY2025 number at 0.01%, changed 0.0% from a year prior.
  • Return on Equity hit 0.01% in Q4 2023 for ProQR Therapeutics, up from 0.01% in the prior quarter.
  • Over the last five years, Return on Equity for PRQR hit a ceiling of 0.0% in Q3 2021 and a floor of 0.01% in Q4 2022.
  • Historically, Return on Equity has averaged 0.01% across 3 years, with a median of 0.01% in 2023.
  • Biggest five-year swings in Return on Equity: decreased -1bps in 2022 and later changed 0bps in 2023.
  • Tracing PRQR's Return on Equity over 3 years: stood at 0.0% in 2021, then plummeted by -115bps to 0.01% in 2022, then rose by 30bps to 0.01% in 2023.
  • Business Quant data shows Return on Equity for PRQR at 0.01% in Q4 2023, 0.01% in Q3 2023, and 0.01% in Q2 2023.